Welcome to our dedicated page for Synaptics SEC filings (Ticker: SYNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Synaptics Incorporated filings document results reporting, governance changes, capital-structure actions and proxy disclosures for the semiconductor company. Form 8-K reports furnish quarterly and annual operating results, supplemental earnings materials and related GAAP and non-GAAP measures tied to revenue, margins, expenses and per-share results.
Other filings cover board-approved share repurchase authorization, amendments to bylaws, universal-proxy and advance-notice provisions, remote meeting mechanics, uncertificated shares and an exclusive-forum provision under Delaware corporate law. The definitive proxy statement documents shareholder voting matters, director elections, executive compensation, equity awards and pay-versus-performance disclosures.
Synaptics Incorporated filed a Form S-8 to register additional common stock for employee plans, including 1,900,000 shares issuable under its Amended and Restated 2019 Equity and Incentive Compensation Plan and 1,500,000 shares available for purchase under its Amended and Restated 2019 Employee Stock Purchase Plan, pursuant to General Instruction E.
The Board approved both plans on July 29, 2025, and stockholders approved them on October 28, 2025, the effective date for each plan.
Synaptics (SYNA) reported Q1 FY26 results with net revenue of $292.5 million, up 13.5% year over year, driven by strength in Core IoT. Gross margin was 42.6% versus 46.9% a year ago as IP licensing declined and amortization on acquired intangibles increased. The company posted a net loss of $20.6 million (basic and diluted $(0.53) per share), an improvement from a $23.1 million loss.
By category, Core IoT revenue rose to $103.6 million from $59.6 million, Enterprise & Automotive was $147.7 million (roughly flat), and Mobile declined to $41.2 million from $50.5 million as IP licensing fell. Operating cash flow was $30.2 million versus $(11.4) million a year ago, and cash and cash equivalents increased to $459.9 million from $391.5 million in June 2025. The company repurchased $7.2 million of stock.
Long-term debt remains $850.0 million (4.00% 2029 notes and 0.75% 2031 convertible notes); no borrowings were outstanding on the $350.0 million revolver. Shares outstanding were 39,095,464 as of September 2025; as context, the company reported 38,990,073 shares outstanding as of October 30, 2025.
Synaptics Incorporated furnished an update on operations by announcing results for the fiscal quarter ended September 27, 2025. The company issued a press release and posted supplemental earnings materials on its investor website.
The press release is included as Exhibit 99.1 and is furnished under Item 2.02, which means it is not deemed filed under Section 18 of the Exchange Act nor incorporated by reference into other filings.
Synaptics (SYNA) disclosed a Form 4 showing a director acquired 3,036 shares of common stock at $0 on November 3, 2025, increasing direct beneficial ownership to 25,226 shares. The filing notes these were restricted stock units (RSUs) that vest quarterly, with full vesting on November 3, 2026, or, for a director not standing for re‑election, on the date of the company’s 2026 Annual Meeting of Stockholders.
Synaptics Inc. (SYNA) disclosed a director equity transaction on Form 4. On 11/03/2025, the director acquired 3,036 shares of common stock at $0 per share under an equity award, bringing total directly held shares to 10,958.
The award reflects restricted stock units (RSUs) that vest in quarterly installments, with full vesting by November 3, 2026, or for a director not standing for re-election, on the date of the company’s 2026 Annual Meeting of Stockholders. No derivative securities were reported in Table II.
Synaptics (SYNA) disclosed a Form 4 showing a director acquired 3,036 shares of common stock on 11/03/2025 from a restricted stock unit grant at a stated price of $0. Following the transaction, the director beneficially owns 40,977 shares directly.
The award vests in equal quarterly installments, with one-fourth of the RSUs vesting each quarter until fully vested on November 3, 2026, or, for a director not standing for re-election, on the date of the company’s 2026 Annual Meeting of Stockholders. This reflects routine director equity compensation and a time-based vesting schedule.
Synaptics, Inc. (SYNA) disclosed an insider transaction on a Form 4. A company director acquired 3,036 shares of common stock on 11/03/2025 at a price of $0, increasing direct beneficial ownership to 21,657 shares.
The acquisition reflects vesting of restricted stock units (RSUs), which are scheduled to vest quarterly until fully vested on November 3, 2026, or, for a director not standing for re‑election, on the date of the Issuer’s 2026 Annual Meeting of Stockholders.
Synaptics (SYNA) director reported an equity grant. On 11/03/2025, a director acquired 3,036 shares of common stock for $0, reflected as a restricted stock unit award. Following the transaction, the director beneficially owned 14,334 shares, held directly.
The award vests in equal quarterly installments, with one-fourth vesting each quarter until fully vested on November 3, 2026, or, for a director not standing for re‑election, on the date of the company’s 2026 Annual Meeting of Stockholders.
Synaptics (SYNA) disclosed that a director acquired 3,036 shares of common stock on 11/03/2025 at $0 under a Code A transaction, increasing direct holdings to 11,838 shares.
The award is tied to restricted stock units that vest quarterly until fully vested on November 3, 2026, or, if the director does not stand for re-election, on the date of the 2026 Annual Meeting of Stockholders.
Synaptics (SYNA) Form 4: A company director reported an award of 3,036 shares of common stock on 11/03/2025 at a reported price of $0, reflecting a restricted stock unit grant. Following this transaction, the director beneficially owned 45,719 shares, held directly.
The award vests in equal quarterly installments, with one-fourth of the RSUs vesting each quarter until fully vested on November 3, 2026, or, for a director not standing for re-election, on the date of the company’s 2026 Annual Meeting of Stockholders.